Shire International Licensing BV Netherlands

Shire is a global specialty biopharmaceutical company founded in 1986. Shire aims those with life-limiting illnesses helping a better life.

Shire seeks to achieve this through multiple therapeutic areas in medicine specialist to develop, produce and sell. Shire's activities are housed in two divisions:

"Human Genetic Therapies" focused on genetic diseases such as Hunter syndrome, Fabry disease and hereditary angioedema.
Specialty Products' represents the therapeutic areas of ADHD, Nephrology, Hematology and Gastroenterology.

Shire group is structured as two autonomous businesses supported by global corporate functions; business unit structure that enables small molecule entities to thrive under Shire Specialty Pharma and protein therapeutics to emerge from Shire Human Genetic Therapies
Type: NORMAL
Address: Strawinskylaan 847, 1077XX Amsterdam
Website: www.shirenederland.nl
Phone: +31 20 407 8425
 
This website requires Flash Player 9 or later. If you can not view this site you probably need to update your system with this plug-in for your browser.